|
2016
|
Invention
|
Ophthalmic formulations.
The present invention relates to an ophthalmic formulation which compri... |
|
|
Invention
|
Combination, kit and method of reducing intraocular pressure.
The present invention is directed ... |
|
|
Invention
|
Method of reducing intraocular pressure in humans.
Provided herein is a method of reducing intra... |
|
|
Invention
|
Anhydrous polymorphs of [(2r,3s,4r,5r)-5-(6-(cyclopentylamino)-9h-purin-9-yl)-3,4-dihydroxytetrah... |
|
2015
|
Invention
|
Methods of preventing, reducing or treating macular degeneration.
The present invention is direc... |
|
|
Invention
|
Methods of preventing, reducing or treating macular degeneration. The present invention is direct... |
|
2014
|
Invention
|
Method of reducing intraocular pressure in humans. Provided herein is a method of reducing intrao... |
|
|
Invention
|
Combination, kit and method of reducing intraocular pressure. 1 agonist is Compound A, ((2R,3S,4R... |
|
|
Invention
|
A method of providing ocular neuroprotection. Provided herein are compounds of Formula I, composi... |
|
|
Invention
|
Ophthalmic formulations. The present invention relates to an ophthalmic formulation which compris... |
|
|
Invention
|
Method of providing ocular neuroprotection.
Provided herein are compounds of Formula I, composit... |
|
2013
|
Invention
|
Method of reducing intraocular pressure in humans.
Provided herein are compounds of Formula I, c... |
|
|
Invention
|
Anhydrous polymorphs of (2r,3s,4r,5r)-5-(6-(cyclopentylamino)-9h-purin-9-yl)-3,4-dihydroxytetrahy... |
|
2012
|
Invention
|
Purine derivatives as adenosine a1 receptor agonists and methods of use thereof. The invention re... |
|
2011
|
Invention
|
Adenosine compounds and their use thereof. 1 adenosine receptor agonists, particularly for reduci... |
|
|
Invention
|
Adenosine compounds and their use thereof. The present invention is directed to a benzyloxy cyclo... |
|
|
Invention
|
Method of reducing intraocular pressure in humans using n6-cyclopentyladenosine (cpa), cpa deriva... |
|
|
Invention
|
Method of reducing intraocular pressure in humans using n6 -cyclopentyladenosine (cpa), cpa deriv... |
|
|
Invention
|
Combination compositions for reducing intraocular pressure. 1 receptor agonist. Also provided her... |
|
|
Invention
|
Combination compositions of adenosine a1 agonists and carbonic anhydrase inhibitors for reducing ... |
|
|
Invention
|
Combination compositions of adenosine a1 agonists and non-selective beta-adrenergic receptor bloc... |
|
|
Invention
|
Combination, kit and method of reducing intraocular pressure. The present invention is directed t... |
|
2010
|
Invention
|
Purine derivatives and methods of use thereof. The invention relates to Purine Derivatives having... |
|
|
Invention
|
Ophthalmic formulation and method of manufacture thereof.
Provided herein is an ophthalmic formu... |
|
|
Invention
|
Ophthalmic formulation and method of manufacture thereof. Provided herein is an ophthalmic formul... |
|
|
Invention
|
Method of reducing intraocular pressure in humans. Provided herein are compounds of Formula... |
|
|
Invention
|
Method of reducing intraocular pressure in humans. Provided herein are compounds, compositions, a... |
|
|
Invention
|
Method of reducing intraocular pressure in humans. Provided herein are compounds of Formula I, co... |
|
|
Invention
|
Antibodies against flagellin and uses thereof.
The present invention provides a novel class of m... |
|
2009
|
Invention
|
Indenoisoquinolinone analogs and methods of use thereof.
The present invention relates to Indeno... |
|
|
Invention
|
Substituted tetracyclic 1h-indeno [1,2-b]pyridine-2(5h)-one analogs thereof and uses thereof.
Pr... |
|
|
Invention
|
Substituted tetracyclic 1h-indeno (1,2-b) pyridine-2 (5h)-one analogs thereof and uses thereof. P... |
|
|
Invention
|
N-benzyl substituted pyridyl porphyrin compounds and methods of use thereof.
The present inventi... |
|
2008
|
Invention
|
Method of preventing contrast-induced nephropathy.
The present invention relates to methods of p... |
|
|
Invention
|
Indenoisoquinolinone analogs and methods of use thereof. The present invention relates to Indenoi... |
